SITC 2022 Supporters

SITC gratefully acknowledges the following supporters of the society's 37th Annual Meeting & Pre-Conference Programs.

37th Annual Meeting

Platinum

Agenus, Inc.
Amgen
AstraZeneca Pharmaceuticals LP
Bristol Myers Squibb
Incyte Corporation

Gold

Genmab US, Inc
Sanofi US Services, Inc.

Silver

AbbVie
Alkermes, Inc.
Janssen Pharmaceutical Research & Development, LLC
Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc. (MSD)

Bronze

BeiGene USA, Inc.
Iovance Biotherapeutics
Novartis Pharmaceuticals Corporation
Pfizer, Inc.

Copper

Bayer Healthcare Pharmaceuticals Inc. (Young Investigator Travel Awards)
Immatics Biotechnologies GmbH (The CheckPoints Party)
Nanobiotix
Personalis, Inc. (The CheckPoints Party)
Veranome Biosystems (Young Investigator Travel Awards)

 

Primer on Tumor Immunology and Cancer ImmunotherapyTM

Bronze

Genentech, a member of the Roche Group
Incyte Corporation
Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc. (MSD)
Pfizer, Inc.

Combination Therapy: Applying Learnings from Past Successes and Failures to Future Treatments (SITC Workshop)

Silver

Bristol Myers Squibb
Incyte Corporation
Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc. (MSD)

Bronze

Alkermes, Inc.
Genmab US, Inc.

Combination Therapy: Using Novel Approaches to Identify Novel Biomarkers, Inform Patient Selection, and Design Trials

Gold

AstraZeneca Pharmaceuticals LP
Bristol Myers Squibb

Silver

Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc. (MSD)

Supporters as of October 13, 2022